Closed
SectorHealthcare
33.15 2.85
24h
Min
32.54
Max
33.15
Income | -27M -12M |
---|---|
Sales | -24M 150M |
P/E Sector Avg | 28.748 51.198 |
EPS | 0.436 |
Profit margin | -7.894 |
Employees | 674 |
EBITDA | -27M 18M |
Recommendations | Buy |
---|---|
12 Months Forecast | +20.66% upside |
Next Earnings | 5 sie 2025 |
---|
Market Cap | -366M 1.8B |
---|---|
Previous open | 30.3 |
Previous close | 33.15 |
By Acuity
50%
50%
166 / 380 Ranking in Healthcare
By Trading Central
Confidence
Weak Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 40 USD 20.66%
High 44 USD
Low 36 USD
Based on 3 Wall Street analysts offering 12 month price targets forSupernus Pharmaceuticals Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$